---
layout: splash
title: 휴젤 (145020)
excerpt: 휴젤의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 168,800 | <span style="color: tomato">4.8<small>%</small></span> | Q:제약 | 35.1 | 2.5 | - |

<!-- more -->

<br>
> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 보툴리눔톡신, 필러 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2015년 12월 24일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 한선호, 문형진 (각자 대표집행임원) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.hugel.co.kr](http://www.hugel.co.kr){:target="_blank"} |

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;14 | | [지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240214002046){:target="_blank"} |
|  | | [매출액또는손익구조30%(대규모법인은15%)이상변동              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240214900852){:target="_blank"} |
|  | | [연결재무제표기준영업(잠정)실적(공정공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240214900752){:target="_blank"} |
| 02&#x2011;13 | | [주요사항보고서(자기주식취득신탁계약체결결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240213001291){:target="_blank"} |
|  | | [[기재정정]주식매수선택권부여에관한신고](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240213001288){:target="_blank"} |
|  | | [풍문또는보도에대한해명(미확정)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240213900666){:target="_blank"} |
| 02&#x2011;08 | | [기업설명회(IR)개최              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240208900309){:target="_blank"} |
|  | | [결산실적공시예고              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240208900308){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![145020](/stock/images/145020.png){: .align-center}

<br>
> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 168,800 | <span style="color: tomato">4.8<small>%</small></span> | <span style="color: tomato">6.6<small>%</small></span> | <span style="color: tomato">3.7<small>%</small></span> | <span style="color: tomato">14.4<small>%</small></span> | <span style="color: tomato">49.0<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">25.7<small>%</small></span> | 43.3<small>%</small> | 0.59 | -27.2<small>%</small> | -11.2<small>%</small> | -0.9 |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 35.1 | 2.5 | - | - |

<br>

{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/145020/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=145020){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A145020&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=145020){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/145020){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/145020/financial-summary){:target="_blank"} |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![145020](/stock/images/145020_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 25.7<small>%</small> | 43.3<small>%</small> | 0.59 | -27.2<small>%</small> | -11.2<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 33.7<small>%</small> | 42.7<small>%</small> | 0.79 | -18.9<small>%</small> | -7.3<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -17.8<small>%</small> | 26.5<small>%</small> | -0.67 | -40.1<small>%</small> | -24.9<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -31.8<small>%</small> | 27.2<small>%</small> | -1.17 | -40.8<small>%</small> | -25.9<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -23.7<small>%</small> | 30.5<small>%</small> | -0.78 | -34.8<small>%</small> | -21.3<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 11.5<small>%</small> | 30.7<small>%</small> | 0.38 | -15.3<small>%</small> | -5.8<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -8.1<small>%</small> | 31.3<small>%</small> | -0.26 | -36.2<small>%</small> | -22.6<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 8.2<small>%</small> | 31.1<small>%</small> | 0.26 | -24.8<small>%</small> | -12.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | -24.0<small>%</small> | 27.9<small>%</small> | -0.86 | -34.9<small>%</small> | -21.5<small>%</small> |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![145020](/stock/images/145020_corr.png){: .align-center}

|       | [HK이노엔](/195940/) | [대웅](/003090/) | [삼성카드](/029780/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [동화기업](/025900/) | [롯데웰푸드](/280360/) | [JB금융지주](/175330/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![145020](/stock/images/145020_2x.png){: .align-center}

<br>
> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}